Cardiovascular Toxicity of Angiogenesis Inhibitors Among Patients With Cancer in Taiwan: A Nested Case-Control Study.

Journal Information

Full Title: J Am Heart Assoc

Abbreviation: J Am Heart Assoc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"these administrative databases are based on the international classification of diseases ( icd ) for cancer and disease coding (data s1 and s2 ).; we identified 298 253 patients who were aged >=20 years with a new diagnosis of colorectal cancer liver cancer kidney cancer cervical cancer or ovarian cancer from the tcr between january 1 2009 and december 31 2017 (figure s1 and data s1 ).; diagnoses were validated using the codes of procedure and examination (data s2 ).; the details about covariate selection are provided in figure s1 and data s2 .; composite scores of the charlson and elixhauser comorbidity indexes were used to assess the patient's overall medical condition to assess and adjust the effect of underlying cardiovascular risks we divided individuals into high-risk intermediate-risk and low-risk groups (data s3 ).; data s1 tables s1-s4 figures s1-s2 click here for additional data file."

Code Sharing
Evidence found in paper:

"Disclosures None."

Evidence found in paper:

"Sources of Funding This study was sponsored by a grant (110wf‐phd‐01) from Taipei Medical University‐Wan Fang Hospital."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025